Markets:

Overview

News

Currencies

International

Treasuries

Perspective Therapeutics, Inc. Common Stock (NY:CATX)

3.525 +0.965 (+37.70%)

Streaming Delayed Price Updated: 11:59 AM EST, Jan 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Perspective Therapeutics, Inc. Common Stock

< Previous 1 2 3 Next >

Gapping stocks in Monday's session ↗

October 20, 2025

Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

October 10, 2025

Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 10, 2025

Via Benzinga

Earnings Scheduled For May 12, 2025 ↗

May 12, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

These stocks are moving in today's session ↗

October 20, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 20, 2025

Via Benzinga

Top movers analysis in the middle of the day on 2025-10-20: top gainers and losers in today's session. ↗

October 20, 2025

Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Which stocks are experiencing notable movement on Friday? ↗

October 10, 2025

Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

This Aptiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗

October 10, 2025

Via Benzinga

PERSPECTIVE THERAPEUTICS INC (NYSEARCA:CATX) Surpasses Q2 2025 Revenue Estimates with Narrower Loss ↗

August 13, 2025

Perspective Therapeutics Inc (CATX) reported strong Q2 2025 revenue, beating estimates by 84%, with a narrower-than-expected loss. The company advances its radiopharmaceutical pipeline, including...

Via Chartmill

Perspective Therapeutics Reports Q2 Loss ↗

August 13, 2025

Via The Motley Fool

Topics Economy

Earnings Scheduled For August 13, 2025 ↗

August 13, 2025

Via Benzinga

A Look Ahead: Perspective Therapeutics's Earnings Forecast ↗

August 12, 2025

Via Benzinga

What's going on in today's session ↗

June 03, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 03, 2025

Via Benzinga

Which stocks are moving on Tuesday? ↗

June 03, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Via Chartmill

Top movers in Friday's pre-market session ↗

April 11, 2025

As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 11, 2025

Via Benzinga

Earnings Scheduled For March 26, 2025 ↗

March 26, 2025

Via Benzinga

Perspective Therapeutics' Cancer-Focused Radiotherapy Portfolio Has Upside Potentional, Says Analyst ↗

March 13, 2025

H.C. Wainwright & Co. initiates a Buy rating on Perspective Therapeutics, citing promising cancer radiotherapy assets.

Via Benzinga

Perspective Therapeutics Touts Encouraging Updated Data From Gastrointestinal Cancer Trial, Stock Soars ↗

January 24, 2025

Perspective Therapeutics shares interim results for [212Pb]VMT-α-NET trial, showing promising safety, stable disease cases, and anti-tumor activity.

Via Benzinga

Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks ↗

January 17, 2025

Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with unknowns.

Via Investor's Business Daily

Topics Government

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 21, 2024

Via Benzinga

Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings ↗

November 21, 2024

Via Benzinga

Topics Stocks

Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights ↗

October 30, 2024

Novartis aims to enhance Pluvicto's market presence while exploring growth in multiple sclerosis and expanding its radioligand therapy portfolio.

Via Benzinga

S&P 500 Moves Higher; BlackRock Reports Upbeat Results ↗

October 11, 2024

Via Benzinga

Topics Stocks

Gold Gains 1%; Wells Fargo Shares Gain After Q3 Earnings ↗

October 11, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 11, 2024

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.